Jasbir Seehra
Chief Executive Officer at KEROS THERAPEUTICS, INC.
Net worth: 14 M $ as of 2024-04-29
Network origin in Jasbir Seehra first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 24 | |
| Subsidiary | Biotechnology | 18 | |
| Public Company | Pharmaceuticals: Major | 16 | |
Ember Therapeutics, Inc. /Old/
 Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY.
4
| Extinct | Pharmaceuticals: Major | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jasbir Seehra via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Compliance Officer Public Communications Contact Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Zikani Therapeutics, Inc.
 Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA. | Drugstore Chains | Director of Finance/CFO Director/Board Member Chairman Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Undergraduate Degree | |
Eloxx Pharmaceuticals Ltd.
 Eloxx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Eloxx Pharmaceuticals Ltd. provides biopharmaceutical research and development services. The firm specializes in the discovery, development, and commercialization of drug compounds for the treatment of genetic diseases. It focuses on the treatment of diseases caused by nonsense mutations, including Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, and Tay-Sachs Hurler syndrome. Its focus areas encompass clinical drug development and target drugs discovery programs. The company was founded by Silvia Noiman and Shmuel Tuvia in 2013 and is headquartered in Herzliya, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
| Stanford University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
| RADIUS HEALTH, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| DNIB UNWIND INC | Biotechnology | Chairman Chief Executive Officer Comptroller/Controller/Auditor | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Masters Business Admin Undergraduate Degree | |
Pontifax Management Co. Ltd.
 Pontifax Management Co. Ltd. Investment ManagersFinance Pontifax Management Co. Ltd. (Pontifax) is a venture capital firm founded in 2004 by Eliyahu Hurvitz. The firm is headquartered in Herzliya Pituach, Israel. | Investment Managers | Chief Executive Officer Founder Private Equity Investor | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Artax Biopharma, Inc.
 Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Director/Board Member Director/Board Member | |
Pontifax (Israel) IV LP
 Pontifax (Israel) IV LP Financial ConglomeratesFinance Part of Pontifax Management Co. Ltd., Pontifax (Israel) IV LP is an investment services provider. The private company is based in Hertsliya, Israel and was founded in 2015. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| EMBER THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| University of Massachusetts | College/University | Undergraduate Degree Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ALECTOR, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Pulmatrix Operating Co., Inc.
 Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Director/Board Member Director/Board Member | |
| SCISPARC LTD. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Suffolk University | College/University | Graduate Degree Masters Business Admin | |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PULMATRIX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| STEALTH BIOTHERAPEUTICS CORP | Biotechnology | Director of Finance/CFO Director/Board Member | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member | |
Nutrinia Ltd.
 Nutrinia Ltd. Pharmaceuticals: MajorHealth Technology Nutrinia Ltd. develops bioactive feed supplements for infant formulas and animal feed. The firm is involved in broad intellectual property protection, industrial processes envelopment, conducting additional clinical trials and obtaining regulatory approval for the supplementation of pre-term and infant formulas with Insulin. The company was founded by Naim Shehadeh in 2003 and is headquartered in Ramat-Gan, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Vico Therapeutics BV
 Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Undergraduate Degree Undergraduate Degree | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree | |
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Operating Officer | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Doctorate Degree | |
Arrakis Therapeutics, Inc.
 Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arrakis Therapeutics, Inc. operates as a biopharmaceutical company. It develops rna-targeted small molecule medicines focused on neurologic, cancer, and rare genetic diseases. The company was founded by Russell C. Petter, Alan E. Walts, Jennifer C. Petter and Raj Bhikhu Parekh in 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder Founder | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Masters Business Admin Masters Business Admin | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
| PREVAIL THERAPEUTICS INC. | Biotechnology | Director/Board Member Director/Board Member | |
| VBI VACCINES INC. | Biotechnology | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin | |
| ERECH FINANCE CAHALACHA LTD | Medical Specialties | Director/Board Member Director/Board Member | |
Paros Bio, Inc.
 Paros Bio, Inc. BiotechnologyHealth Technology Paros Bio, Inc. is a company that specializes in gene therapy for neurodegenerative diseases. The company is based in Boston, MA. Specifically, they are developing a gene replacement approach to treat autosomal dominant Alzheimer's disease caused by mutations in the presenilin 1 gene. The company's therapy directly addresses the underlying genetic cause of the disease. | Biotechnology | Director/Board Member Director/Board Member | |
| EDITAS MEDICINE, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Gemini Therapeutics Sub, Inc.
 Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Gemini Therapeutics Sub, Inc. engages in the development of treatments for age-related macular degeneration (AMD) and linked ocular disorders. Its multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. The company was founded by James McLaughlin, Johanna Seddon, Paul Barlow and Andrew Herbert in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member |
Statistics
International
| United States | 42 |
| Israel | 9 |
| Netherlands | 2 |
Sectoral
| Health Technology | 35 |
| Consumer Services | 13 |
| Finance | 4 |
| Retail Trade | 2 |
Operational
| Director/Board Member | 378 |
| Corporate Officer/Principal | 142 |
| Independent Dir/Board Member | 100 |
| Director of Finance/CFO | 87 |
| Chairman | 64 |
Most connected contacts
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Daniel Geffken | 53 |
| Terry McGuire | 51 |
| Raj Bhikhu Parekh | 50 |
| Tomer Kariv | 46 |
| Ran Nussbaum | 38 |
| Jean George | 33 |
| Martijn Kleijwegt | 33 |
| Daniel Lynch | 32 |
| Mary Gray | 27 |
| Gregory Weaver | 22 |
| Joseph Hernandez | 20 |
| Alon Lazarus | 18 |
| Alan Walts | 17 |
| Julius Knowles | 17 |
- Stock Market
- Insiders
- Jasbir Seehra
- Company connections